These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 10636244)
21. Camptothecin suppresses nitric oxide biosynthesis in RAW 264.7 macrophages. Chiou WF; Chou CJ; Chen CF Life Sci; 2001 Jun; 69(6):625-35. PubMed ID: 11476184 [TBL] [Abstract][Full Text] [Related]
22. The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW 267.4 macrophage cells: a role of Raf-1 in lipopolysaccharide signaling. Chakravortty D; Kato Y; Sugiyama T; Koide N; Mu MM; Yoshida T; Yokochi T J Immunol; 2001 Feb; 166(3):2011-7. PubMed ID: 11160250 [TBL] [Abstract][Full Text] [Related]
23. Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression. Maggi LB; Sadeghi H; Weigand C; Scarim AL; Heitmeier MR; Corbett JA Diabetes; 2000 Mar; 49(3):346-55. PubMed ID: 10868955 [TBL] [Abstract][Full Text] [Related]
24. Screening of edible Japanese plants for nitric oxide generation inhibitory activities in RAW 264.7 cells. Kim OK; Murakami A; Nakamura Y; Ohigashi H Cancer Lett; 1998 Mar; 125(1-2):199-207. PubMed ID: 9566716 [TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009 [TBL] [Abstract][Full Text] [Related]
27. Timing of prostaglandin exposure is critical for the inhibition of LPS- or IFN-gamma-induced macrophage NO synthesis by PGE2. Harbrecht BG; Kim YM; Wirant EA; Simmons RL; Billiar TR J Leukoc Biol; 1997 Jun; 61(6):712-20. PubMed ID: 9201262 [TBL] [Abstract][Full Text] [Related]
28. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. Ajizian SJ; English BK; Meals EA J Infect Dis; 1999 Apr; 179(4):939-44. PubMed ID: 10068590 [TBL] [Abstract][Full Text] [Related]
29. Coumarins from Angelica decursiva inhibit lipopolysaccharide-induced nitrite oxide production in RAW 264.7 cells. Ishita IJ; Nurul Islam M; Kim YS; Choi RJ; Sohn HS; Jung HA; Choi JS Arch Pharm Res; 2016 Jan; 39(1):115-26. PubMed ID: 26474585 [TBL] [Abstract][Full Text] [Related]
30. Physiological concentrations of 17beta-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system. Hayashi T; Yamada K; Esaki T; Muto E; Chaudhuri G; Iguchi A J Cardiovasc Pharmacol; 1998 Feb; 31(2):292-8. PubMed ID: 9475272 [TBL] [Abstract][Full Text] [Related]
31. Nicotine enhancement of lipopolysaccharide/interferon-gamma-induced cytotoxicity with elevating nitric oxide production. Chen YC; Shen SC; Lin HY; Tsai SH; Lee TJ Toxicol Lett; 2004 Nov; 153(2):191-200. PubMed ID: 15451549 [TBL] [Abstract][Full Text] [Related]
32. Impaired response to interferon-gamma in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide. Llovera M; Pearson JD; Moreno C; Riveros-Moreno V Br J Pharmacol; 2001 Jan; 132(2):419-26. PubMed ID: 11159690 [TBL] [Abstract][Full Text] [Related]
33. Inhibition by 1'-acetoxychavicol acetate of lipopolysaccharide- and interferon-gamma-induced nitric oxide production through suppression of inducible nitric oxide synthase gene expression in RAW264 cells. Ohata T; Fukuda K; Murakami A; Ohigashi H; Sugimura T; Wakabayashi K Carcinogenesis; 1998 Jun; 19(6):1007-12. PubMed ID: 9667738 [TBL] [Abstract][Full Text] [Related]
34. Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine. Weisz A; Cicatiello L; Esumi H Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):209-15. PubMed ID: 8645207 [TBL] [Abstract][Full Text] [Related]
35. Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-gamma-induced IkappaB degradation in RAW264.7 macrophages. Murakami A; Matsumoto K; Koshimizu K; Ohigashi H Cancer Lett; 2003 May; 195(1):17-25. PubMed ID: 12767507 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of inducible nitric oxide synthesis by oxidized lipoprotein(a) in a murine macrophage cell line. Moeslinger T; Friedl R; Volf I; Brunner M; Koller E; Spieckermann PG FEBS Lett; 2000 Jul; 478(1-2):95-9. PubMed ID: 10922476 [TBL] [Abstract][Full Text] [Related]
37. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. Gao JJ; Filla MB; Fultz MJ; Vogel SN; Russell SW; Murphy WJ J Immunol; 1998 Nov; 161(9):4803-10. PubMed ID: 9794412 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of tricyclic fused coumarin sulfonates and their inhibitory effects on LPS-induced nitric oxide and PGE2 productions in RAW 264.7 macrophages. Jang HL; El-Gamal MI; Choi HE; Choi HY; Lee KT; Oh CH Bioorg Med Chem Lett; 2014 Jan; 24(2):571-5. PubMed ID: 24360561 [TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory activity of 4-arylcoumarins from endophytic Streptomyces aureofaciens CMUAc130 in murine macrophage RAW 264.7 cells. Taechowisan T; Tuntiwachwuttikul P; Lu C; Shen Y; Lumyong S; Taylor WC Immunol Invest; 2007; 36(2):203-11. PubMed ID: 17365020 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1'-1'-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L. Raghav SK; Gupta B; Shrivastava A; Das HR Eur J Pharmacol; 2007 Mar; 560(1):69-80. PubMed ID: 17292351 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]